Pancreatobiliary Carcinoma — Trials

Pancreatobiliary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,131 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 699
Recruiting: 403
Ph III recruiting: 36
Growth YoY: +23.4%
Industry share: 30%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (303)

clinicaltrialsPublishedShowing 251–254 of 254 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05779917	Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers	recruiting	Phase 1	30	Second Affiliated Hospital of Guangzhou Medical UniversityOTHER	1	Jun 25, 2024	clinicaltrials
NCT06126406	Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors	recruiting	Phase 1	60	Chongqing Precision Biotech Co., LtdINDUSTRY	1	Nov 13, 2023